Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Emergent Biosolutions Inc. buy Benchmark Co.

Emergent Biosolutions Inc.
Start price
€2.04
11.04.24 / 50%
Target price
€4.65
11.04.25
Performance (%)
76.96%
Price
€3.61
22:26
Summary
This prediction is currently active. With a performance of 76.96% the BUY prediction by Benchmark_Co_ is a big success. This prediction currently runs until 11.04.25. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Emergent Biosolutions Inc. 66.911%
iShares Core DAX® 0.000%
iShares Nasdaq 100 0.626%
iShares Nikkei 225® 1.568%
iShares S&P 500 0.334%

Comments by Benchmark_Co_ for this prediction

In the thread Emergent Biosolutions Inc. diskutieren
Prediction Buy
Perf. (%) 76.96%
Target price 4.653
Change
Ends at 11.04.25

Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Ratings data for EBS provided by MarketBeat

Benchmark Co. 
0
Report Share
11.04.24

Stopped prediction by Benchmark_Co_ for Emergent Biosolutions Inc.

buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.53
07.03.24
€4.58
07.03.25
42.91%
22:26

Benchmark Co. 
07.03.24 50%
buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€11.36
10.04.23
€20.27
10.04.24
-82.04%
11.04.24

Benchmark Co. 
10.04.23 50%